- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00601211
Bioequivalency Study of 5 mg Piolocarpine Tablets Under Fed Conditions
January 19, 2018 updated by: Roxane Laboratories
A Single Dose, Two-Treatment, Two-Period, Two Sequence Crossover Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fed Conditions
The objective of this study was the bioequivalence of a Roxane Laboratories' Pilocarpine Tablets, 5 mg, to SALAGEN® Tablets, 5 mg (MGI Pharma) under fed conditions using a single-dose, 2-treatment, 2-period, crossover design.
Study Overview
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Austin, Texas, United States, 78759
- CEDRA Clinical Research, LLC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening.
Exclusion Criteria:
- Positive test for HIV, Hepatitis B, or Hepatitis C.
- Treatment with known enzyme altering drugs.
- History of allergic or adverse response to Pilocarpine or any comparable or similar product.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Bioequivalence
Time Frame: Baseline, Two period, Seven day washout
|
Baseline, Two period, Seven day washout
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2003
Primary Completion (Actual)
September 1, 2003
Study Completion (Actual)
September 1, 2003
Study Registration Dates
First Submitted
January 15, 2008
First Submitted That Met QC Criteria
January 25, 2008
First Posted (Estimate)
January 28, 2008
Study Record Updates
Last Update Posted (Actual)
January 23, 2018
Last Update Submitted That Met QC Criteria
January 19, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Stomatognathic Diseases
- Mouth Diseases
- Salivary Gland Diseases
- Xerostomia
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Cholinergic Agents
- Cholinergic Agonists
- Miotics
- Muscarinic Agonists
- Pilocarpine
Other Study ID Numbers
- PILO-02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Mouth
-
Maastricht University Medical CenterCompletedPatients of Advanced Age (≥ 70 Years) With a Clinical Diagnosis of Chronic Dry MouthNetherlands
-
Dow University of Health SciencesCompleted
-
Riyadh Colleges of Dentistry and PharmacyUnknownDry SocketSaudi Arabia
-
National University of MalaysiaCompletedXerostomia | Dry MouthMalaysia
-
Procter and GambleCompleted
-
Roxane LaboratoriesCompletedDry MouthUnited States
-
Roxane LaboratoriesCompleted
-
British University In EgyptCompletedSalivary Gland Diseases | Dry MouthEgypt
-
SunBio, Inc.NAMSA; RudacureCompleted
Clinical Trials on Pilocarpine
-
Wills EyeCompleted
-
Emory UniversityGeorgia Institute of TechnologyCompleted
-
Glaukos CorporationCompletedDry Eye Disease | Kerato Conjunctivitis SiccaUnited States
-
Glaukos CorporationCompletedPresbyopiaUnited States
-
Samsung Medical CenterUnknownCataract | PresbyopiaKorea, Republic of
-
Pontificia Universidad Catolica de ChileFormulario MAgistral Farmacias AhumadaCompletedXerostomia | Primary Sjogren | Secondary SjogrenChile
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedHead and Neck Cancer | XerostomiaUnited States, Canada
-
Alcon ResearchCompletedAngle-closure GlaucomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast Cancer | Vaginal DrynessUnited States